Base4Base 4GAAP revenue YoY -1.16% → base 4. The base score is anchored to the GAAP revenue YoY band before transcript, EPS, and guidance adjustments.+Transcript0Transcript 0GAAP revenue is clean, no distortion. Mild 1.16% decline driven by ~40% operational COVID product decline partially offset by non-COVID +9% operational growth.+EPS0EPS 0GAAP EPS YoY -503.34% vs rev YoY -1.16% (spread -502.18pp, massively outside -5pp). OI cross-check: OI YoY -35.58% (OI spread -34.42pp, outside -5pp, same direction). BUT OI is contaminated by $4.4B non-cash intangible asset impairments in current quarter AND $2.9B impairments in prior year Q4. Ex-charge OI (both years): current $3,688M + $4,400M = $8,088M; prior $5,725M + $2,900M = $8,625M. Ex-charge OI YoY -6.23%. Ex-charge OI spread -5.07pp, barely outside -5pp boundary. GAAP EPS wildly distorted by impairments in both years. Ex-charge OI shows operating performance roughly in line with mild revenue decline. Adjusted EPS $0.66 ahead of expectations. Override to 0+Guidance0Guidance 0FY2026 guidance reaffirmed unchanged at $59.5-$62.5B revenue and $2.80-$3.00 adjusted EPS. No change to prior guidance → 0=Final4